Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by rivermoneyon Oct 30, 2018 7:02am
197 Views
Post# 28892549

Here is why Trellis agreement will happen!!!

Here is why Trellis agreement will happen!!!
Vancouver, British Columbia--(Newsfile Corp. - August 29, 2018) - New Age Farm Inc. (CSE: NF) (OTC Pink: NWGFF) (FSE: 0NF) (www.newagefarminc.com) ("New Age Farm" or the "Company") is pleased to announce that the Company has acquired two cash flowing marijuana properties in the state of Oregon. Cave Junction, Portland, Oregon The Cave Junction property consists of 11 acres divided into two separate legal lots. Cave Junction, Oregon is historically known as one of the best micro climates in the world for successful outdoor cultivation of cannabis. The property, which was previously the Althouse Nursery, was converted into a state of the art outdoor and greenhouse cannabis cultivation facility in 2015. Since then, the property has been operated by Trellis Farms ("Trellis"), an experienced and successful cannabis cultivation company. Currently Trellis is operating on one of the legal plots and holds a OLCC license for the cultivation of 40,000 square feet of recreational cannabis. Trellis has plans to expand the cultivation to inhabit the second legal plot and add an additional 40,000 square feet of canopy. Joshua Bartch, Chief Executive Officer of the Company, stated: "We are extremely pleased to be announcing today's property acquisition. Not only does this acquisition add $3,000,000 USD in hard, appreciating assets on the Company's balance sheet, but it also gives the Company a strong monthly cash flow. I believe that this is just the first of many land and property acquisitions that the Company holds in its future."
Bullboard Posts